Posts

Showing posts with the label pharmacology

Injectable Lipid-Lowering Therapies

Image
Cardiovascular disease (CVD) remains a leading cause of death globally, with elevated lipid levels being a significant risk factor. Traditionally, lipid-lowering therapies, such as statins, have been the cornerstone of managing dyslipidemia. However, not all patients achieve optimal lipid levels with these treatments, and some may experience side effects. In recent years, injectable lipid-lowering therapies have emerged as an effective alternative or adjunct to oral medications, offering new hope for patients struggling to control their cholesterol levels. This article explores the various types of injectable lipid-lowering therapies, their mechanisms of action, clinical benefits, and potential future developments. Types of Injectable Lipid-Lowering Therapies 1. PCSK9 Inhibitors Mechanism of Action Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors work by targeting PCSK9, a protein that degrades low-density lipoprotein receptors (LDLR) on liver cells. By inhibiting PCSK9...

FDA Fast Track Designation for Alzheimer’s Treatment

Image
  Alzheimer’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide, posing significant challenges for patients, caregivers, and healthcare systems. Despite extensive research, effective treatments remain elusive. In this context, the FDA Fast Track designation represents a beacon of hope, accelerating the development and review of potential therapies for Alzheimer’s disease. This article delves into the significance, process, and implications of the FDA Fast Track designation for Alzheimer’s treatments. Understanding FDA Fast Track Designation The Fast Track designation is a regulatory process designed by the U.S. Food and Drug Administration (FDA) to expedite the review of drugs intended to treat serious conditions and address unmet medical needs. This designation aims to get promising new therapies to patients sooner, without compromising safety and efficacy standards. Criteria for Fast Track Designation To qualify for Fast Track designati...

Pharmacology Refresh Cards: Noradrenaline - Norepinephrine

Noradrenaline  -  norepinephrine Drug name Sympathomimetic   (Vasopressor) Group Stimulates alpha-receptors in arterial and venous beds and beta 1 receptors of heart, resulting in peripheral vasoconstriction and stimulation of heart rate and contractility. Coronary vasodilation occurs secondary to enhanced myocardial contractility. Mechanism of action duration Interval dose Uses Cont. infusion 0.01–0.4 µg/kg/min IV infusion via a central vein           Septic shock ,with low SVR Severe hypertension may occur if noradrenaline is given to patients taking tricyclic antidepressants since tricyclics block the uptake of noradrenaline into nerve endings. Drug interaction Bradycardia Hypertension Arrhythmias Myocardial ischaemia peripheral ischaemia Side effects Hypovolaemic ...

New Guidelines for Preventing Colchicine Drug Interactions

A new set of evidence-based guidelines provides an algorithm for reducing colchicine doses to prevent toxicity in patients who are also taking drugs such as cyclosporine, ketoconazole, ritonavir, clarithromycin, azithromycin, verapamil extended release (ER), or diltiazem ER. The research group was led by Robert A. Terkeltaub, MD, from the Veterans Administration San Diego Medical Center in California, and the new report appears in the August issue of Arthritis & Rheumatism .

you can test yourself and answer this daily test by comment the perfect answer and the winner will be post tomorrow :

1 Ondansetron HCL is used for : a- Hypertension b- Angina pectoris c- Prophylaxis of migraine d- Anti-emetic

Practice Questions (Circulation)

1. Prothrombin is a ____ globulin and is produced by the _____. A. Alpha, Kidney  B. Alpha, Liver  C. Beta, Kidney  D. Beta, Liver 2. The right coronary artery divides to form the posterior interventricular artery and the ___ artery. A. Marginal  B. LVC  C. RVC  D. LAD 3. Blood flowing into the cardiac veins enters the _______ next. A. Coronary Sinus  B. Left Ventricle  C. Right Ventricle  D. Left Atrium 4. If you are using a stethoscope and trying to detect the tricuspid valve which of the following would be the best location? A. Within 2 inches of the xyphoid process  B. On the right side of the sternum  C. On the left side of the sternum near the midpoint  D. On the left side of the sternum near the midpoint of the sixth rib 5. Which of the following occurs during ventricular systole? A. Increased aortic pressure  B. Increased ventricular volume  C. Dup heart sound  D. P wave 6. Which of the following occurs during ventricular diastole? A. Increased aortic pressure  B. Increased ven...

Practice Questions (pharmacology)

1. Which of the following is the antidote for the toxin Benzodiazepines? A. Flumazenil  B. Methylene blue  C. Deferoxamine  D. Alkalinize urine 2. Which of the following is the antidote for the toxin Lead? A. Naloxone  B. Nitrite  C. CaEDTA  D. Dialysis 3. Which of the following is the primary site of activity for the drug Warfarin? A. Kidney  B. Liver  C. Blood  D. Heart 4. Lansoprazole is not used in which of the following cases? A. Gastritis  B. Peptic Ulcers  C. Zollinger-Ellison syndrome  D. Thalamus hypertrophy 5. Which of the following drugs is associated with the reaction of Cinchonism? A. Valproic acid  B. Quinidine  C. Isoniazid  D. Ethosuximide 6. Which of the following drugs is associated with the reaction of hepatitis? A. Valproic acid  B. Quinidine  C. Isoniazid  D. Ethosuximide 7. Which of the following drugs is associated with the reaction of Stevens-Johnson syndrome? A. Valproic acid  B. Quinidine  C. Isoniazid  D. Ethosuximide 8. Which of the following drugs is associ...

Practice Questions (pharmacology)

1. Which of the following is not a side effect of the cholinoreceptor blocker (Atropine)? A. Increased pulse  B. Urinary retention  C. Constipation  D. Mydriasis 2. Which of the following is not a side effect of the Ace Inhibitor (Captopril)? A. Rash  B. Angioedema  C. Cough  D. Congestion 3. Which of the following is not a side effect of the Vasodilator (Nifedipine)? A. Nausea  B. Flush appearance  C. Vertigo  D. Sexual dysfunction 4. Which of the following is not a side effect of the Sympathoplegics (Clonidine)? A. Hypertension  B. Asthma  C. Dry oral cavity  D. Lethargic behavior 5. Which of the following is not a side effect of the Dieuretics (Loop dieuretics)? A. Alkalosis  B. Nausea  C. Hypotension  D. Potassium deficits 6. Which of the following is not an effect of the drug (Isoflurane)? A. Elevated lipid levels  B. Nausea  C. Increased blood flow to the brain.  D. Decreased respiratory function 7. Which of the following is not an effect of the drug (Midazolam)? A. Amnesia  B. D...